Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT ID: NCT02140671
Last Updated: 2014-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
33370 participants
OBSERVATIONAL
2012-05-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Develop and Implement Asthma Controlling Strategies
NCT00005731
The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment
NCT03460106
Develop and Implement Asthma Controlling Strategies (2)
NCT00005733
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742
Develop and Implement Asthma Controlling Strategies (1)
NCT00005732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Finland programme focused on accurate diagnosis, training and education of healthcare professionals and patients and early use of anti-inflammatory therapy. The programme successfully improved medication compliance, reduced asthma hospital admissions, reduced asthma-related benefit claims and reduced the overall cost of asthma to the Finnish Government.
To test the validity and sustainability of an enhanced asthma management model for the UK, the BLF proposes to undertake a pilot initiative in England. The pilot will focus on: improving diagnostic accuracy through analysis of GP asthma registers; increasing asthma education among healthcare professionals; assessment of risk and control of patient's asthma; supportive self-management and education of people with asthma.
It is anticipated that the pilot will lead to measureable and significant improvements in asthma management, including:
* Reduced number of severe exacerbations (asthma hospitalisation, A\&E attendance and oral steroid rescue)
* Improved diagnostic accuracy (and reduction of diagnostic doubt)
* Improved implementation of recognised asthma guidelines, including appropriate step wise management of patients
The pilot will also aim to increase the proportion of patients on the asthma register with an asthma management plan and a recorded asthma control test therefore supporting higher levels of control, and will promote peer-to-peer health care professional asthma education and knowledge sharing to establish an asthma-training legacy.
The pilot model will be sustainable and reproducible across England and the devolved nations (Scotland, Wales and Northern Ireland). Whilst the core aspects of an agreed national model will be rolled out across the pilot site, it will be tailored and refined through local collaboration (primary care, secondary care and commissioners) to help attain local targets in line with regional differences, needs and priorities.
Results from the pilot will be reported 15 months after project initiation on site (July/August 2014)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with an asthma diagnosis
No interventions assigned to this group
Patients where there is diagnostic doubt
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High rates of hospital admissions (aged 3-65)
* High asthma prevalence
* High percentage of patients who have had an asthma review in the previous 15 months.
Exclusion Criteria
3 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Lung Foundation
OTHER
Research in Real-Life Ltd
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Price
Role: PRINCIPAL_INVESTIGATOR
Reasearch in Real Life Ltd
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORO3112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.